1650 participants
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-07
- Start Date:
- 2023-12-01
- Completion:
- 2033-02-28
Conditions
- NASH With Fibrosis
- MASH With Fibrosis
Interventions
- DRUG
No Results Yet